高尿酸血症运动干预的研究进展

doi:10.12114/j.issn.1007-9572.2024.0209

摘要/Abstract

摘要： 随着人类生产和生活方式的改变，高尿酸血症（HUA）的发病率呈逐年升高且年轻化态势，严重危害着人类健康，成为阻碍医疗、经济和社会发展的负担。因此，本文从HUA的发病机制、共病关系和运动干预等方面进行综述，基于体医融合的视角，着重分析了不同运动特征对HUA的作用，为HUA患者运动处方的制订提供依据，以期为HUA的防治提供参考，提高HUA及痛风患者的生活质量，助力健康中国建设。

关键词: 高尿酸血症, 发病机制, 共病关系, 运动特征, 综述

Abstract:

With the change of human production and lifestyles, the incidence rate of hyperuricemia (HUA) is increasing year by year and the incidence is showing a younger trend, which seriously endangers human health and becomes a burden hindering the development of medical, economic and social development. Therefore, this paper reviews from the pathogenesis, comorbidity, and exercise intervention of HUA, and focuses on analyzing the effects of different exercise characteristics on HUA based on the perspective of integrating sports and medicine. It provides a basis for the formulation of exercise prescriptions for HUA patients, so as to provide a reference for the prevention and treatment of HUA, improve the quality of life of HUA and gout patients, and contribute to the construction of a healthy China.

Key words: Hyperuricacidemia, Pathogenesis, Comorbidity relationship, Motion feature, Review

王婷婷,唐勇,张文轲,等. 高尿酸血症运动干预的研究进展[J]. 中国全科医学, 2025, 28(30): 3841-3846. DOI: 10.12114/j.issn.1007-9572.2024.0209.
WANG Tingting,TANG Yong,ZHANG Wenke, et al. Research Progress on Exercise Intervention of Hyperuricemia[J]. Chinese General Practice, 2025, 28(30): 3841-3846. DOI: 10.12114/j.issn.1007-9572.2024.0209.

图/表 1

参考文献 51

[1]	LEE J W, KWON B C, CHOI H G. Analyses of the relationship between hyperuricemia and osteoporosis[J]. Sci Rep，2021,11(1):12080. DOI：10.1038/s41598-021-91570-z.
[2]	中华中医药学会.痛风及高尿酸血症中西医结合诊疗指南[EB/OL].（2023-05-31）[2023-12-17].
[3]	CHEN X M, YOKOSE C, RAI S K，et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends：the national health and nutrition examination survey，2007-2016[J]. Arthritis Rheumatol，2019,71(6):991-999. DOI：10.1002/art.40807.
[4]	中国民族卫生协会重症代谢疾病分会，高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识（2023年版）[J]. 中国实用内科杂志，2023,43(6):461-480. DOI：10.19538/j.nk2023060106.
[5]	BORGHI C, AGABITI-ROSEI E, JOHNSON R J，et al. Hyperuricaemia and gout in cardiovascular，metabolic and kidney disease[J]. Eur J Intern Med，2020,80:1-11. DOI：10.1016/j.ejim.2020.07.006.
[6]	JIANG Z, CAO J, SU H，et al. Exercise serum regulates uric acid transporters in normal rat kidney cells[J]. Sci Rep，2022,12(1):18086. DOI：10.1038/s41598-022-22570-w.
[7]	GHERGHINA M E, PERIDE I, TIGLIS M，et al. Uric acid and oxidative stress-relationship with cardiovascular，metabolic，and renal impairment[J]. Int J Mol Sci，2022,23(6):3188. DOI：10.3390/ijms23063188.
[8]	DING R, DENG X, CHEN L，et al. A dose-escalation study of HP501，a highly selective URAT1 inhibitor，in male Chinese patients with hyperuricemia[J]. Sci Rep，2023,13(1):22190. DOI：10.1038/s41598-023-49052-x.
[9]	YANG C, ZHOU D, SHEN Z，et al. Characterization of stereoselective metabolism，inhibitory effect on uric acid uptake transporters，and pharmacokinetics of lesinurad atropisomers[J]. Drug Metab Dispos. 2019 Feb；47(2):104-113. DOI：10.1124/dmd.118.080549.
[10]	HOQUE K M, DIXON E E, LEWIS R M，et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion[J]. Nat Commun，2020,11(1):2767. DOI：10.1038/s41467-020-16525-w.
[11]	DING X, LI M, PENG C，et al. Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion[J]. BMC Vet Res，2019,15(1):180. DOI：10.1186/s12917-019-1886-9.
[12]	YAMAMOTO T, KASAHARA M, UESHIMA K，et al. Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia：TARGET-UA[J]. Clin Exp Nephrol，2024,28(8):764-772. DOI：10.1007/s10157-024-02483-w.
[13]	OHASHI Y, KURIYAMA S, NAKANO T，et al. Urate transporter ABCG2 function and asymptomatic hyperuricemia：a retrospective cohort study of CKD progression[J]. Am J Kidney Dis，2023,81(2):134-144.e1. DOI：10.1053/j.ajkd.2022.05.010.
[14]	SONG M, LI N, YAO Y，et al. Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis[J]. J Cell Mol Med，2019,23(8):4970-4979. DOI：10.1111/jcmm.14337.
[15]	周彬彬，刘冬梅，张卓君，等. 痛风性关节炎急性发作对男性心功能影响的观察性研究[J]. 复旦学报（医学版），2023,50(4):561-566. DOI：10.3969/j.issn.1672-8467.2023.04.012.
[16]	YAZICI O, NARTER F, ERIBIN A，et al. Effect of endothelial dysfunction on the pathogenesis of urolithiasis in patients with metabolic syndrome[J]. Aging Male，2020,23(5):1082-1087. DOI：10.1080/13685538.2019.1675151.
[17]	吴选霞，补娟，张艳敏，等.体检人群代谢综合征及其不同组分高尿酸血症流行特征研究[J].海南医学院学报，2023,29(20):1546-1554. DOI：10.13210/j.cnki.jhmu.20230825.002.
[18]	ALI N, MIAH R, HASAN M，et al. Association between serum uric acid and metabolic syndrome：a cross-sectional study in Bangladeshi adults[J]. Sci Rep，2020,10(1):7841. DOI：10.1038/s41598-020-64884-7.
[19]	WANG T, ZHU X, CHEN Y，et al. Safety and effectiveness of rasburicase in the control of hyperuricemia in pediatric patients with non-hodgkin's lymphoma and acute leukemia：an open-label，single-arm，multi-center，interventional study[J]. Drugs R D，2023,23(2):129-140. DOI：10.1007/s40268-023-00420-y.
[20]	BARAF H S B, KHANNA P P, KIVITZ A J，et al. The COMPARE head-to-head，randomized controlled trial of SEL-212（pegadricase plus rapamycin-containing nanoparticle，ImmTOR^TM）versus pegloticase for refractory gout[J]. Rheumatology（Oxford），2024,63(4):1058-1067. DOI：10.1093/rheumatology/kead333.
[21]	刘敏，孟娟. 基于全科医生视角的《2020年美国风湿病学会痛风治疗指南》解读[J]. 中国全科医学，2021,24(25):3148-3153. DOI：10.12114/j.issn.1007-9572.2021.00.133.
[22]	JIA E T, ZHU H Q, GENG H L，et al. The effects of aerobic exercise on body composition in overweight and obese patients with gout：a randomized，open-labeled，controlled trial[J]. Trials，2022,23(1):75. DOI：10.1186/s13063-022-06695-x.
[23]	CHOI HK, MCCORMICK N, LU N，et al. Population impact attributable to modifiable risk factors for hyperuricemia[J]. Arthritis Rheumatol，2020,72(1):157-165. DOI：10.1002/art.41067.
[24]	LIU S, LIN X, TAO M，et al. Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia：results of a randomized，double-blind，placebo-controlled trial[J]. Lipids Health Dis，2024,23(1):77. DOI：10.1186/s12944-024-02047-7.
[25]	LARSSO S C, BURGESS S, MICHAELSSON K. Genetic association between adiposity and gout：a Mendelian randomization study[J]. Rheumatology（Oxford），2018,57(12):2145-2148. DOI：10.1093/rheumatology/key229.
[26]	杨媛，周光清，李宛霖，等.不同肥胖指标在高尿酸血症风险预测中的应用价值比较研究[J].中国全科医学，2022,25(4):453-460. DOI：10.12114/j.issn.1007-9572.2021.00.281.
[27]	ZHOU Z L, LI K P, LI X Z，et al. Independent and joint associations of body mass index，waist circumference，waist-height ratio and their changes with risks of hyperuricemia in middle-aged and older Chinese individuals：a population-based nationwide cohort study[J]. Nutr Metab，2021,18(1):62. DOI：10.1186/s12986-021-00590-z.
[28]	宋艳玲. 不同运动频次对高尿酸血症患者痛风发作率、血清肌酐水平、尿酸水平及尿pH值的影响[J]. 河北医药，2020,42(21):3214-3217. DOI：10.3969/j.issn.1002-7386.2020.21.003.
[29]	肖晓琴，陈尚茹，姚春，等. 多学科联合饮食与运动管理对高尿酸血症患者干预的实践研究[J]. 中外医学研究，2020,18(1):158-160. DOI：10.14033/j.cnki.cfmr.2020.01.069.
[30]	潘丽英，马春莲，谷涌泉. 6周有氧运动改善不同程度肥胖青少年体质健康的研究[J]. 武汉体育学院学报，2022,56(7):76-83. DOI：10.3969/j.issn.1000-520X.2022.07.010.
[31]	黄叶飞，欧嘉勇，刘琪，等. 不同运动频次对高尿酸血症患者痛风发作影响的研究[J]. 新医学，2018,49(5):355-358. DOI：10.3969/j.issn.0253-9802.2018.05.012.
[32]	HOU Y N, MA R Y, GAO S，et al. The effect of low and moderate exercise on hyperuricemia：protocol for a randomized controlled study[J]. Front Endocrinol，2021,12:716802. DOI：10.3389/fendo.2021.716802.
[33]	NISHIDA Y, IYADOMI M, HIGAKI Y，et al. Influence of physical activity intensity and aerobic fitness on the anthropometric index and serum uric acid concentration in people with obesity[J]. Intern Med，2011,50(19):2121-2128. DOI：10.2169/internalmedicine.50.5506.
[34]	HUANG L L, HUANG C T, CHEN M L，et al. Effects of profuse sweating induced by exercise on urinary uric acid excretion in a hot environment[J]. Chin J Physiol，2010,53(4):254-261. DOI：10.4077/cjp.2010.amk060.
[35]	李杰，施闻，苏晴. 广东省重点运动员高尿酸血症研究与分析[C].广东：2023年全国第九届"中国体能训练科学大会"，2023.
[36]	BEAVERS K M, HSU F C, SERRA M C，et al. The effects of a long-term physical activity intervention on serum uric acid in older adults at risk for physical disability[J]. J Aging Phys Act，2014,22(1):25-33. DOI：10.1123/japa.2012-0018.
[37]	SOUSA M S, SAAVEDRA F J, NETO G R，et al. Resistance training in type 2 diabetic patients improves uric acid levels[J]. J Hum Kinet，2014,43:17-24. DOI：10.2478/hukin-2014-0085.
[38]	FAELLI E, BISIO A, CODELLA R，et al. Acute and chronic catabolic responses to CrossFit® and resistance training in young males[J]. Int J Environ Res Public Health，2020,17(19):7172. DOI：10.3390/ijerph17197172.
[39]	NETO G R, NOVAES J S, SALERNO V P，et al. Does a resistance exercise session with continuous or intermittent blood flow restriction promote muscle damage and increase oxidative stress?[J]. J Sports Sci，2018,36(1):104-110. DOI：10.1080/02640414.2017.1283430.
[40]	贾国瑜，韩涛，高磊，等. 有氧运动和抗阻运动改善非酒精性脂肪肝的随机对照研究[J]. 中华肝脏病杂志，2018,26(1):34-41. DOI：10.3760/cma.j.issn.1007-3418.2018.01.009.
[41]	成晓翠，孙明艳，孙巧云，等. 有氧运动和抗阻运动在痛风患者延续管理中的应用效果比较[J]. 山东医药，2021,61(35):72-75. DOI：10.3969/j.issn.1002-266X.2021.35.020.
[42]	游良华，李维俞，彭中春，等.中等强度有氧运动联合力量训练的运动干预对老年高尿酸血症患者尿酸、身体机能及生活质量的影响[J].广州医药，2022,53(3):83-86. DOI：10.3969/j.issn.1000-8535.2022.03.020.
[43]	李阔弟. 快速力量训练联合有氧运动干预对高尿酸血症患者的效果及氧化应激机制研究[D].天津：天津体育学院，2020.
[44]	李晓丁. 快速力量训练联合有氧运动对高尿酸血症患者血尿酸及炎症因子的干预效果观察[D].天津：天津体育学院，2020.
[45]	唐宇，温永霞，张文旭. 有氧运动联合力量训练对老年高尿酸血症患者的影响[J]. 中国老年保健医学，2021,19(1):15-17. DOI：10.3969/j.issn.1672-2671.2021.01.005.
[46]	VIEIR A F, MORITA CEJ, RAMIS T R，et al. Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults：a double-blind，randomised clinical trial[J]. Br J Nutr，2022,128(10):1975-1989. DOI：10.1017/S0007114521004980.
[47]	侯鹏飞，张校亮，谭慷，等. 基于便携式扫描仪与智能手机的尿酸定量检测技术[J]. 太原理工大学学报，2021,52(2):307-312. DOI：10.16355/j.cnki.issn1007-9432tyut.2021.02.020.
[48]	WU X H, YOU C G. The biomarkers discovery of hyperuricemia and gout：proteomics and metabolomics[J]. PeerJ，2023,11:e14554. DOI：10.7717/peerj.14554.
[49]	HUANG Y, LIU Y, HUANG Q，et al. TMT-based quantitative proteomics analysis of synovial fluid-derived exosomes in inflammatory arthritis[J]. Front Immunol，2022,13:800902. DOI：10.3389/fimmu.2022.800902.
[50]	LIU S, LIU Y, WU X，et al. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology[J]. J Orthop Surg Res，2023,18(1):769. DOI：10.1186/s13018-023-04240-3.
[51]	SOUZA A V, GIOLO J S, TEIXEIRA R R，et al. Salivary and plasmatic antioxidant profile following continuous，resistance，and high-intensity interval exercise：preliminary study[J]. Oxid Med Cell Longev，2019,2019:5425021. DOI：10.1155/2019/5425021.